Skizofrénia: vizsgálatok itt: Japán
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Where
- Bunkyo-ku, Chikugo, Miyakonojō, Ōta-ku, Sapporo, Yokohama, Kanagawa, Zentsujichó
- Életkor
- 5 év to 17 év
- People
- 400 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07424404 · EU 2025-524062-16-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia
- Where
- Aizu-Wakamatsu, Chiba, Fukuoka, Ginowan, Hachiōji, Hadano-shi, Hirakata, Hiratsuka, Ichikawa, Iizuka, Karatsu-shi, Kitakyushu, Kodaira, Komoro, Kōnan, Kumagaya, Kumamoto, Kure, Kyoto, Machida, Maizuru, Matsumoto, Miyakonojō, Miyazaki, Moriguchi, Nagoya, Neyagawa, Okayama, Okinawa, Omuta, Osaka, Ōta-ku, Sagamihara, Saitama, Sapporo, Setagaya City, Shimotsuga, Shimotsuke, tabashi City, Takatsuki, Toki, Tokushima, Tosu, Tottori, Toyoake, Ube, Utsunomiya, Wakayama, Yamagata, Yatsushiro, Yokohama
- Életkor
- 18 év to 65 év
- People
- 250
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06882785 - 3. fázisTaking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Fukuoka, Hachiōji, Hadano, Himeji-Shi, Hiroshima, Iizuka, Kanzaki-Gun Yoshinogari-Cho, Kawasaki-Shi, Kōriyama, Kumamoto, Kyoto, Sakai, Sapporo, Setagaya-Ku, Takamatsu, Takatsuki, Tatebayashi, Toride-shi, Tsu, Wako-Shi, Yokohama, Yoshinogawa
- Életkor
- 55 év to 90 év
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - 2. fázisTaking peopleA Study of Brenipatide in Adult Participants With Schizophrenia
- Where
- Chikugo, Fukushima, Hachinohe, Hiratsuka, Karatsu, Kodaira, Kumamoto, Kurume, Machida, Nagasaki, Sagamihara, Saitama, Tokyo, Toyoake, Yamagata, Yokosuka
- Életkor
- 18 év to 55 év
- People
- 450 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07410507 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Where
- Bunkyo-ku, Chikugo-Shi, Miyakonojō, Ōta-ku, Sapporo, Yokohama, Kanagawa, Zentsujichó
- Életkor
- 13 év to 17 év
- People
- 166 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07288567 · EU 2025-523711-11-00 - 3. fázisTaking peopleTrial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
- Where
- Kure-shi
- Életkor
- 18 év to 74 év
- People
- 450 worldwide
- Run by
- Otsuka Pharmaceutical Co., Ltd.
See details and how to joinNCT05325645 · EU 2022-500583-36-00 - 3. fázisTaking peopleA Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- Where
- Nankoku-shi, Osaka, Suita
- Életkor
- 55 év to 90 év
- People
- 325 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06947941 - 3. fázisTaking peopleA Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia
- Where
- Fukuoka
- Életkor
- 18 év and over
- People
- 100
- Run by
- Otsuka Pharmaceutical Co., Ltd.
See details and how to joinNCT07225712